Catalyst Wire Dossier Catalyst Wire Dossier

combined antiretroviral therapy (cART)

combination antiretroviral therapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for combined antiretroviral therapy (cART), covering 2016-07-12 to 2016-07-12. Get the full timeline:

Most recent: Clinical Trial Update: Values of the Immune Activation Markers CD38 and HLA-DR and the Ratio CD4/CD8 According to the Delay of Combined AntiRetroviral Therapy (c-ART) Initiation in Primary HIV-infected Patients (PRIMIMMUNO)

See pricing